Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024
Friday, Dec 13, 2024 6:12 pm ET
4min read As an investor, I've always been drawn to the stability and predictability of "boring but lucrative" investments. While some may chase the thrill of options and risky stocks, I prefer the steady performance of companies like Morgan Stanley, which, despite being downgraded by Oppenheimer, continues to impress with its strong performance and stable credit quality improvements. This preference for stability extends to my interest in Viridian Therapeutics and its upcoming webcast of Veligrotug Phase 3 THRIVE-2 topline results on December 16, 2024.
The banking industry, much like the broader market, can be volatile and unpredictable. However, Morgan Stanley has stood out as a beacon of stability, transforming under the leadership of James Gorman. Gorman's strategic acquisitions, particularly in wealth management, have turned the bank into a reliable and profitable institution. This transformation highlights the value of stability and predictability in investments, as a "no-surprise" bank like Morgan Stanley deserves a higher valuation than its peers.
Viridian Therapeutics, with its Veligrotug Phase 3 THRIVE-2 trial, offers a similar opportunity for investors seeking stable and predictable growth. The company's previous THRIVE trial results were promising, with a 70% proptosis responder rate and significant improvements in diplopia and Clinical Activity Score (CAS). If the THRIVE-2 results align with these findings, Veligrotug could become a leading treatment for thyroid eye disease (TED), potentially transforming Viridian Therapeutics into a stable, profitable biopharmaceutical company.
The topline results of the Veligrotug Phase 3 THRIVE-2 trial could significantly impact Viridian Therapeutics' regulatory submission timeline and market access strategy. If the results demonstrate Veligrotug's efficacy and safety in treating chronic TED, Viridian could submit a Biologics License Application (BLA) to the FDA in the second half of 2025, as planned. Positive results may also accelerate market access by strengthening Viridian's position in negotiations with payers and healthcare providers.
In conclusion, as an investor who values stability and predictability, I am excited about the upcoming webcast of Veligrotug Phase 3 THRIVE-2 topline results. The potential of Veligrotug to become a leading treatment for TED, combined with Viridian Therapeutics' strong clinical trial data, makes this a compelling investment opportunity. I look forward to the results and the potential growth that this "boring but lucrative" investment could bring.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
_56ef5cf71747658846645.jpeg)
Recover Your Lost Funds with Expert Assistance from BSB Forensic
If you've fallen victim to fraudulent activities involving a company, broker, or account manager, don't lose hope. BSB Forensic specializes in helping individuals recover lost funds through thorough investigation and expert financial recovery strategies.
I personally recommend their trusted services—they successfully assisted me in recovering my lost funds, and I am confident they can help you too.
For more information and to start your recovery process today, visit Bsbforensic. com
yes
If you ever want to change or up your university grades, contact Cybergolden Hacker; he'll get it done and show proof of work done before payment. He's efficient, reliable, and affordable. He can also perform all sorts of hacks, including text, WhatsApp, password decryption, hacking any mobile phone, escaping bankruptcy, deleting criminal records, and the rest.
Email: cybergoldenhacker at gmail dot com
We made contac! The Ancient Alien Theorists were right!
No recent comments, so I'll update things. As of writing this, BoxOfficeMojo is reporting Sinners has reached $236,728,722 worldwide in 17 days. Word of mouth helped it to hardly drop off much, even in third weekend against the opening of Thunderbolts. So it should end up probably over $300 mil before done, not counting home video profits.
A bonified smash!
*finger crossed* It gets some love at the Oscars.
I'd recommen holding everyone like look at what it was December 2024 I think it was wat January2025 maybe the momth after
it went parabolic It's almost I feel doing
the samething. N 83% chance the etf is getting approved I read so I compare it to bitcoin when the inflows n outoutflows started with bitcoin well it will start with xrp' hopefully to be etfs and also I read the sec has to pay xrp or ripple a billion dollars which I think are all good things n indicators thar it's smart to buy now n hold or just hold that's what I'm doing. falling wedge pattern and it's just so viotile it will happen just stay calm an watch as UT goes up n up n up let's all hope for it 🙏
“I want to share my experience with 𝐂𝐚𝐭𝐡𝐞𝐫𝐢𝐧𝐞 𝐄. 𝐑𝐮𝐬𝐬𝐞𝐥𝐥👥Facebook page. Get the edge in crypto trading chat, who has been an exceptional crypto trader. Her trading signals are incredibly accurate, and especially now with Bitcoin soaring, she has helped me generate significant profits. Catherine is honest, trustworthy, and truly committed to her clients’ success. She is not a scam or an imposter—she’s the real deal and genuinely cares about helping people. If you’re considering crypto trading, don’t miss this opportunity. Reach out to her on Facebook and see for yourself!”
Amen to that like Warren buffet says
"when there's blood in the streets buy" he's definitely rite just gotta hold name of the
game...some of the questions I see on
here people really listen to the media then
it's changed an forgotten in ghe news
literally 5 days later not even and
lol its forgotten